Dibyaratna Patgiri1, Mauchumi Saikia Pathak2, Pradeep Sharma3, Tridip Kutum4, Nirmali Mattack4. 1. Demonstrator, Department of Biochemistry, Gauhati Medical College & Hospital , Guwahati, Assam, India . 2. Professor, Department of Biochemistry, Gauhati Medical College & Hospital , Guwahati, Assam, India . 3. Assistant Professor, Department of Biochemistry, Mayo Institute of Medical Sciences , U.P, India . 4. Post-Graduate Trainee, Department of Biochemistry, Gauhati Medical College & Hospital , Guwahati, Assam, India .
Abstract
INTRODUCTION AND OBJECTIVES: Strokes are caused by disruption of the blood supply to the brain. This may result from either blockage or rupture of a blood vessel. Yearly 15 million people worldwide suffer a stroke. India ranks second worldwide in terms of deaths from stroke. The incidence of stroke increases with age affecting the economically productive middle aged population. Hypertension and male sex are other risk factors for stroke. C-Reactive Protein (CRP) is an acute phase protein whose concentration rises in blood following inflammation. Formerly, assays for CRP detected its rise only after significant inflammation. However, recently developed high sensitivity assays (hsCRP) enable the measurement of CRP in individuals who are apparently healthy. Several studies indicate that hsCRP is elevated in individuals who are at risk of developing Coronary Artery Disease or Cerebrovascular events, the elevation may be found years before the first detection of vascular problems. In the absence of other biochemical markers, the present study aimed to evaluate the predictive and diagnostic role of hsCRP in stroke. MATERIALS AND METHODS: The study consisted of 50 patients of acute stroke admitted in Gauhati Medical College and Hospital. The control population consisted of two groups - 50 age and sex matched controls with hypertension (Hypertensive control group) and 50 age and sex matched controls with no obvious disease constituted the Normal control group. hsCRP levels were measured in all the groups and compared statistically. CONCLUSION: hsCRP is an acute phase reactant whose concentration rises in stroke as well as in those at risk. The rise may be identified even before the appearance of risk factors. Hence, hsCRP may be useful as a predictive and diagnostic marker in stroke.
INTRODUCTION AND OBJECTIVES:Strokes are caused by disruption of the blood supply to the brain. This may result from either blockage or rupture of a blood vessel. Yearly 15 million people worldwide suffer a stroke. India ranks second worldwide in terms of deaths from stroke. The incidence of stroke increases with age affecting the economically productive middle aged population. Hypertension and male sex are other risk factors for stroke. C-Reactive Protein (CRP) is an acute phase protein whose concentration rises in blood following inflammation. Formerly, assays for CRP detected its rise only after significant inflammation. However, recently developed high sensitivity assays (hsCRP) enable the measurement of CRP in individuals who are apparently healthy. Several studies indicate that hsCRP is elevated in individuals who are at risk of developing Coronary Artery Disease or Cerebrovascular events, the elevation may be found years before the first detection of vascular problems. In the absence of other biochemical markers, the present study aimed to evaluate the predictive and diagnostic role of hsCRP in stroke. MATERIALS AND METHODS: The study consisted of 50 patients of acute stroke admitted in Gauhati Medical College and Hospital. The control population consisted of two groups - 50 age and sex matched controls with hypertension (Hypertensive control group) and 50 age and sex matched controls with no obvious disease constituted the Normal control group. hsCRP levels were measured in all the groups and compared statistically. CONCLUSION: hsCRP is an acute phase reactant whose concentration rises in stroke as well as in those at risk. The rise may be identified even before the appearance of risk factors. Hence, hsCRP may be useful as a predictive and diagnostic marker in stroke.
Authors: Jonas Andersson; Lars Johansson; Per Ladenvall; Per-Gunnar Wiklund; Birgitta Stegmayr; Christina Jern; Kurt Boman Journal: Cerebrovasc Dis Date: 2009-04-24 Impact factor: 2.762
Authors: Mitchell S V Elkind; Kristen Coates; Wanling Tai; Myunghee C Paik; Bernadette Boden-Albala; Ralph L Sacco Journal: BMC Neurol Date: 2006-10-16 Impact factor: 2.474
Authors: Adomas Bunevicius; Andrius Radziunas; Sarunas Tamasauskas; Arimantas Tamasauskas; Edwards R Laws; Giorgio Iervasi; Robertas Bunevicius; Vytenis Deltuva Journal: J Neurooncol Date: 2018-02-19 Impact factor: 4.130
Authors: Antonio Bernabe-Ortiz; Rodrigo M Carrillo-Larco; Robert H Gilman; Liam Smeeth; William Checkley; J Jaime Miranda Journal: Ann Epidemiol Date: 2021-12-16 Impact factor: 3.797
Authors: Kayla A Riggs; Parag H Joshi; Amit Khera; James D Otvos; Philip Greenland; Colby R Ayers; Anand Rohatgi Journal: Am J Prev Cardiol Date: 2022-08-22
Authors: Baraa K Al-Khazraji; Mark B Badrov; Mason Kadem; Navena R Lingum; Trevor B Birmingham; Joel Kevin Shoemaker Journal: Physiol Rep Date: 2019-10